STAT

STAT+: Pharmalittle: Pfizer and BioNTech say vaccine is effective against Covid-19 variant; U.S. to join COVAX initiative

The Pfizer-BioNTech Covid-19 vaccine appears to work just as well against a fast-spreading variant first identified in the U.K. as it does against earlier forms of the coronavirus.
Source: Alex Hogan/STAT

Top of the morning to you, and a fine one it is, as the much-discussed change in Washington, D.C., offers the

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT1 min gelesen
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min gelesenMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min gelesenMedical
STAT+: Pharmalittle: FDA Panel Endorses Pfizer Covid-19 Vaccine; Meanwhile, Sanofi Shot Suffers Major Setback
A panel of outside experts recommended the FDA issue an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech.